CLDN18.2

Close
Menu

Are you a healthcare professional?

This site is intended only for Healthcare Professionals who are interested in the management of gastric cancer and/or gastro-oesophageal junction cancers.

I AM NOT A HEALTHCARE PROFESSIONAL BUT WOULD LIKE MORE INFORMATION ON GASTRIC/GASTRO-OESOPHAGEAL JUNCTION CANCERS

This website is a educational scientific resource, funded and developed by Astellas Pharma Ltd.
MAT-BX-ZOL-2024-00036 JAN2025

Books on bookshelves with overlay of abstract gray concentric circles

CLDN18.2 resources

Download additional resources to learn more about how to consistently test, interpret, and report CLDN18.2 in G/GEJ cancer.

Global RING Trial Poster

Global Ring Study Determining Reproducibility and Comparability of CLDN18 Testing in Gastric Cancer

IHC Assay Guide

Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.

eLearning Center

Access a self-guided CLDN18.2 educational program.

Visit the eLearning Site

ECP Testing Poster
2023

Analytical and Clinical Presentation of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples for Patient Identification in Two Phase 3 Trials of Zolbetuximab

IMAGE

Contact us if you’d like to know more

We are more than happy to support you in case you have questions. Feel free to reach out via e-mail.

 

 

IMAGE

Access to and use of this site is subject to the Terms of use available here. This Site was developed and is maintained by Astellas. Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.

All case reviews and consensus scoring have been independently conducted by the members of the CLDN18.2 Expert Committee. 

©2024 Astellas Pharma, Inc. All rights reserved.

MAT-BX-ZOL-2024-00036 JAN2025